2024. Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study. Biomolecules and Biomedicine. (Jun. 2024). DOI:https://doi.org/10.17305/bb.2024.10512.